Skip to content

Effect of Vojta or Reflex locomotion therapy on the gross motor function of children with cerebral palsy

Effect of Vojta or Reflex locomotion therapy on the gross motor function of children with cerebral palsy - VTCP

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014775
Enrollment
30
Registered
2018-05-25
Start date
2018-05-04
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G80

Interventions

Group 1: RL therapy will be carried out once a week for 2 months, by a trained physiotherapist. This therapist will also train the parents in the exercises to establish a daily home program (between o

Sponsors

Faculty of Medicine, University of Murcia, Spain. V. de la Arrixaca University Hospital, Department of Traumatology, Murcia, Spain.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Months to 18 Months

Inclusion criteria

Inclusion criteria: Male and female between zero and 18 months of age with neurological findings consistent with neuromotor disorders were recruited when the family inquired Reflex Locomotion therapy in different physiotherapy clinics in Spain, Germany and London (United Kingdom). The diagnosis of cerebral palsy can not be always confirmed within such an early stage, and neuromuscular disorders or other conditions that could affect motor performance need to be ruled out; therefore, the data of the children were included retrospectively on a later stage when the diagnosis was confirmed. In addition, participants’ parents or guardians gave informed consent. The previous therapeutic trajectory was not considered within the exclusion criteria for two reasons: their effect would be already included within the speed of motor development before RL, and also because all the children were controlled with themselves.

Exclusion criteria

Exclusion criteria: Data of the children are excluded if they introduced another therapy input or they dropped any of the previous ones during the two months of RL intervention (pharmacological, surgical or rehabilitative). For ethical reasons, this was not specified to the families who agreed to join the trial, in order not to influence their future therapeutic decisions.

Design outcomes

Primary

MeasureTime frame
Outcome Name: Gross motor function Method of measuremente: Gross Motor Funcion Measure (GMFM). Timepoint: after 2 months of treatment

Secondary

MeasureTime frame
Outcome Name: Therapy Dossagement Method of measuremente: Times/day Timepoint: after 2 months of treatment

Countries

Germany, Spain, United Kingdom

Contacts

Public ContactJose Manuel Sanz-Mengibar

University of Murcia

jmsmengibar@hotmail.com+447726764081

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026